Cargando…
Sulfasalazine decreases mouse cortical hyperexcitability
OBJECTIVE: Currently prescribed antiepileptic drugs (AEDs) are ineffective in treating approximately 30% of epilepsy patients. Sulfasalazine (SAS) is an US Food and Drug Administration (FDA)–approved drug for the treatment of Crohn disease that has been shown to inhibit the cystine/glutamate antipor...
Autores principales: | Alcoreza, Oscar, Tewari, Bhanu P., Bouslog, Allison, Savoia, Andrew, Sontheimer, Harald, Campbell, Susan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771750/ https://www.ncbi.nlm.nih.gov/pubmed/31211419 http://dx.doi.org/10.1111/epi.16073 |
Ejemplares similares
-
Sulfasalazine decreases astrogliosis‐mediated seizure burden
por: Alcoreza, Oscar, et al.
Publicado: (2022) -
Glioma‐induced peritumoral hyperexcitability in a pediatric glioma model
por: Chaunsali, Lata, et al.
Publicado: (2020) -
Dysregulation of Ambient Glutamate and Glutamate Receptors in Epilepsy: An Astrocytic Perspective
por: Alcoreza, Oscar B., et al.
Publicado: (2021) -
Gut metabolite S‐equol ameliorates hyperexcitability in entorhinal cortex neurons following Theiler murine encephalomyelitis virus‐induced acute seizures
por: Gallucci, Allison, et al.
Publicado: (2021) -
Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy
por: Tewari, Bhanu P., et al.
Publicado: (2018)